Tag Archives: AI

AI-Powered Health: Naheed Kurji of Cyclica Takes a Deep Dive into Artificial Intelligence for the Healthcare Industry



Our guest this week is Naheed Kurji, the CEO and Co-founder of Cyclica, which joined StartUp Health way back in 2014. He’s going to get us up to speed on the world of AI-powered drug discovery. We’ll learn how artificial intelligence and machine learning are speeding up our ability to identify molecules and find new uses for market-tested drugs. Naheed will give us an inside look at how Cyclica is specifically trying to reshape this market, then he’ll zoom way out. As the chair of the Alliance for Artificial Intelligence in Health, Naheed can help us understand where the AI for health industry is going.

Join us at the StartUp Health Festival @ HLTH, Nov 13-16, 2022, in Las Vegas to meet Naheed Kurji in person.


Learn more and connect with the team at Cyclica.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.
Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

 


How Nightingale Is Redefining Preventative Health



Join us in Miami Beach in March for StartUp Health @ ViVE 2022: startuphealth.com/vive

Nightingale Health, a Finnish company that StartUp Health backed in 2016, uses a new kind of blood testing to predict future disease risk so that people can change the course of their health before it’s too late. They’ve designed a way to analyze blood samples that pulls 250 times more data from that sample than a typical test. They use artificial intelligence and machine learning to correlate that data with future disease risk, like diabetes and heart disease. Then they put the result in simple terms so that patients can see trends and take action.

This year, Nightingale took three big strides forward. They went public on the Finnish Nasdaq, which gave them capital to scale globally. They rolled out at-home testing kits so more people can benefit from Nightingale’s disease prediction. And they acquired a genomics company that will allow them to bake genetic information into their app and provide people with even more personalized health assessments.

We sat down with Nightingale CEO and Co-founder Teemu Suna to hear more about their blood testing technology and how it could change preventative health globally by getting patients to see their potential future and then change the course of their health.

Join us in Miami Beach in March at StartUp Health @ ViVE 2022 to meet Health Transformers: startuphealth.com/vive

Learn more and connect with the team at Nightingale.

Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.